ArticleCancer gene therapy2013

Potent CD4+ T-cell epitope P30 enhances HER2/neu-engineered dendritic cell-induced immunity against Tg1-1 breast cancer in transgenic FVBneuN mice by enhanced CD4+ T-cell-stimulated CTL responses.

Y Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.